Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 240 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-09 | 172901 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-03-02 | 184086 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-03-16 | 186589 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189662 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-08-04 | 195091 |
APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2023-07-13 | 2023-07-21 | 198508 |
APO-INDAPAMIDE 2.5MG TABLETS | 2.5MG | TABLET | Resolved | 2023-08-04 | 2023-08-18 | 201168 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-08-18 | 2023-09-28 | 202403 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-09-07 | 2023-12-01 | 203822 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-11-06 | 2024-03-01 | 209363 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210701 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-01-05 | 2024-02-02 | 215221 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215227 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
APO-MIDODRINE | 2.5MG | TABLET | Actual shortage | 2024-02-09 | 2024-03-22 | 219162 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223043 |
APO-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-03 | 225773 |
APO-PERINDOPRIL/AMLODIPINE | 2.5MG 3.5MG | TABLET | Resolved | 2023-12-01 | 2023-12-15 | 212386 |
APO-REPAGLINIDE | 2.0MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 481 |
APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-06-28 | 2017-11-30 | 14219 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 |